Once upon a time the magic pill was penicillin. It was Marie Curie’s miraculous radium. It was Jonas Salk’s polio vaccine.
These days it is the stem cell.
New ways to treat and cure disease often meet with skepticism, but the ones that work eventually secure the respect of investors, practitioners and patients, moving into both the medical paradigm and the marketplace. If the researchers working in the stem cell field—and the analysts covering the field—are right, regenerative medicine is knocking on the door of the paradigm. Once it wins entry, the rewards for investors could be … [visit site to read more]
Similar posts: